– MOU signed with V Lab America USA – MOU with Clemedi Switzerland Publications GATA2 Haploinsufficiency caused by G492A mutation associated with familial AML (2018). AS Cancer Biology MS-275, A Class 1 HDAC inhibitor Augments GLP-1R Agonism to Improve Glycemic Control and Reduce Obesity in DIO Mice. e Life. 2020; 9: e52212 PHLPP1 promotes neutral lipid accumulation through AMPK/ChREBP-dependent lipid uptake and fatty acid synthesis pathways. Volume 25, Issue 2, 18 February 2022, 103766 Biochemical and Biophysical Research Communications 25 Nov 2020, 534:461-467 Analysis of cellular models of clonal evolution reveals co-evolution of imatinib and HSP90 inhibitor resistance.